Frequently Asked Questions

If you purchase a device, you may return it for a refund within 30 days of receipt (Details). The device is effective for most patients within the first two weeks of daily use, but some customers may require three or four weeks to experience results. If you need a few extra days - or even a couple of extra weeks - just call us or email us and we will gladly extend the refund period.

If you do not see your question listed below, please chat with us online, call us, or email us and we will provide you with the information you need.

You can purchase your device through our website or over the phone by calling us at 800.692.4380.

If you purchase a device, you may return it for a refund within 30 days of receipt (Details). The device is effective for most patients within the first two weeks of daily use, but some customers may require three or four weeks to experience results. If you need a few extra days - or even a couple of extra weeks - just call us or email us and we will gladly extend the refund period.

Please call us, email us or chat with us if you have any questions.

The Fisher Wallace Stimulator® is a United States medical device. We do not take insurance payments and customers must inquire with Health Canada regarding reimbursement. The HSPCS code for the device is E0720.

The device delivers mild electrical stimulation to the brain through sponge electrodes placed above the sideburns. When used on the head, the device has been shown in medical studies to stimulate the production of neurochemicals, such as serotonin, GABA and endorphins, which are responsible for improving sleep and suppressing chronic pain.

When used on the body to treat site-specific pain (the Chronic Pain Treatment Kit includes body straps to secure the electrodes and a special instruction manual), the electrical stimulation influences the way peripheral nerves signal pain, reducing the sensation of pain.

Yes. The device does not have any contraindications with medication.
Yes. The device can work for patients who have not found success with medication.

If you purchase a device, you may return it for a refund within 30 days of receipt (Details). The device is effective for most patients within the first two weeks of daily use, but some customers may require three or four weeks to experience results. If you need a few extra days - or even a couple of extra weeks - just call us or email us and we will gladly extend the refund period.

The electrical current is so gentle that many patients do not feel it at all, while some may feel tingling at the sponge contact sites. Mild optic nerve stimulation may also occur, which may produce the sensation of flashing light in the corner of the eyes - this is normal and harmless.

Cranial Electrotherapy Stimulation (CES) devices such as the Fisher Wallace Stimulator® are approved by Health Canada for the treatment of insomnia and pain.

Transcranial Direct Current Stimulation (tDCS) is not approved by Health Canada.  Transcranial Direct Current Stimulation (tDCS) is typically used for research purposes, and as a result, can be very expensive because it often requires office visits and doctor supervision during treatment sessions. Insurance companies will not reimburse patients for purchasing or using tDCS for “off label” uses such as the treatment of insomnia.

The Fisher Wallace Stimulator® and ECT both deliver alternating current to the brain for therapeutic effect, but at vastly different doses. The Fisher Wallace Stimulator® provides very gentle stimulation therapy designed for daily home use without doctor supervision - it does not cause a seizure or serious side effects. ECT, while often effective, is performed in a hospital while the patient is under anesthesia and is designed to induce a seizure. ECT often causes memory loss. Following are more differences:

1. ECT delivers 800 – 1000+ mA of electricity, which causes a seizure.

The Fisher Wallace Stimulator® delivers 1 – 4 mA of electricity, which does not cause a seizure. In fact, the Fisher Wallace Stimulator® is recommended for treating substance abuse patients who are prone to seizures.

2. ECT is administered when a patient is under anesthesia.

The Fisher Wallace Stimulator® delivers such a mild current that patients typically wear it while reading a book, on the computer or watching TV. The stimulation from our device is rarely perceived and is not uncomfortable.

3. ECT delivers a large amount of electricity in a single dose.

The Fisher Wallace Stimulator® delivers a gentle amount of electricity on a daily basis.

4. ECT typically costs $30,000 and, while effective initially, its effects wear off.

The Fisher Wallace Stimulator® costs $699 and the effects do not wear off when the device is used on a regular basis.

5. ECT is indicated to treat severe depression. The Fisher Wallace Stimulator® can be used to treat temporary or situational depression as well as chronic, severe depression. Our device has also been approved by Health Canada for the treatment of insomnia and pain.

People having cardiac pacemakers of the demand or sensing type should be aware that actions of the pacemaker may be inhibited or otherwise interfered with by this device. Please consult your physician if you have a pacemaker.

If you have metal of any kind or medical devices located inside your head (such as shrapnel or shunts), you should consult a physician before using our device.

The safety of using CES devices during pregnancy has not been established, although ECT (Electro Convulsive Therapy) is cleared for use with pregnant women. Please note that the device has been prescribed by many doctors for the treatment of postpartum depression.

Many people report positive changes during or shortly after the first 5-10 treatment sessions. Results in treating insomnia are typically experienced faster than in treating depression and anxiety. The device should be used daily for 30 days before making a decision regarding effectiveness. While level 2 is the recommended starting dosage level, the device may be used safely at level 3 and 4, should level 2 not produce positive results after two weeks.

When being used to treat chronic pain (on the body), the device often reduces symptoms within a few treatment sessions.

Resting quietly is best, but one can engage in activities such as reading, watching TV, using the computer, or talking on the phone during a treatment session.

When used cranially to treat insomnia, depression and anxiety, 1 in 500 patients report a mild headache upon using the device.

One in 250 patients may experience an increase in wakefulness immediately after using the device. If this occurs, the device should not be used within three hours of bedtime.

Although not a side effect, improper use of the device may result in minor electrode irritation - this can occur if the sponges are not thoroughly wet before use. Please watch the instructional video and read the instruction manual thoroughly before using the device. People with very sensitive skin may find that the sponge electrodes, even when wet, cause a slight irritation to the skin - but this is very rare.

Ideally, you should use the device twice a day for 20 minutes until your symptoms go into remission. If you no longer have symptoms, you can stop using the device and then renew treatment if the symptoms return. The device has been on the market for decades without any reports of long-term negative effects. Many patients have used the device for years.

Yes. You can search for our device Medical Device Active License by going to the following Health Canada webpage, clicking on Active License Search and typing in Fisher Wallace into the search field.

Our technology should not be confused with Electroconvulsive Therapy (ECT) or Transcranial Magnetic Stimulation (TMS).

More questions? Please call or email us at (800) 692-4380 or info@fisherwallace.ca. Voicemail and emails are responded to promptly during regular business hours, M-F, 10 am - 5 pm, EST.